Product Information
FT CHILD PAIN REL 120 MG SUPP is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.2442 per EA under NDC 70677127001. Its NADAC has been published 62 times since Jul 30, 2025.
FDA first approved this application on Apr 6, 1987.
Strength
120 mg/1
Manufacturer
Strategic Sourcing Services LLCNDC
70677127001
Classification
Generic
Dosage Form
SUPPOSITORY
Route
RECTAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHENApproval Type
Generic (ANDA)
FDA Application
ANDA070607FDA Approved
4/6/1987
On Market Since
4/7/2025
Price Statistics
The NADAC for FT CHILD PAIN REL 120 MG SUPP has been published 62 times since Jul 30, 2025, and over the history we have for it it has declined 5.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2442 per EA |
|---|---|
| All-time high | $0.2572 (Aug 13, 2025) |
| All-time low | $0.2221 (Dec 17, 2025) |
| 52-week high | $0.2442 |
| 52-week low | $0.2221 |
| Median price | $0.2416 |
| Average price | $0.2369 |
| Largest weekly change | +4.1% (May 20, 2026) |
| Weeks tracked | 62 |
| Tracking since | Jul 30, 2025 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strategic Sourcing Services LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Acetaminophen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FT CHILD PAIN REL 120 MG SUPP?
The current National Average Drug Acquisition Cost (NADAC) for FT CHILD PAIN REL 120 MG SUPP, manufactured by Strategic Sourcing Services LLC, is $0.2442 per EA (NDC 70677127001), effective Sep 30, 2026.
How has the price of FT CHILD PAIN REL 120 MG SUPP changed over time?
Over the history we have for it, the NADAC for FT CHILD PAIN REL 120 MG SUPP has declined 5.1%. It has been tracked across 62 weekly CMS publications since Jul 30, 2025.
What are the highest and lowest recorded NADAC prices for FT CHILD PAIN REL 120 MG SUPP?
Since Jul 30, 2025, the NADAC for FT CHILD PAIN REL 120 MG SUPP has ranged from a low of $0.2221 (Dec 17, 2025) to a high of $0.2572 (Aug 13, 2025), with a median of $0.2416 per EA.
Are there cheaper alternatives to FT CHILD PAIN REL 120 MG SUPP?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FT CHILD PAIN REL 120 MG SUPP in a comparable dosage form, but none are currently priced below it.
Who manufactures FT CHILD PAIN REL 120 MG SUPP?
FT CHILD PAIN REL 120 MG SUPP (NDC 70677127001) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.